Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|March 31, 2015
Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapseJakub Radocha, Luděk Pour, Tomáš Pika, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2022
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry DataVladimir Maisnar, Ludek Pour, Ivan Spicka, et al.
Biomedicines|October 27, 2022
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with PlasmacytomasMartin Stork, Sabina Sevcikova, Tomas Jelinek, et al.
British Journal of Haematology|November 2, 2021
Identification of patients at high risk of secondary extramedullary multiple myeloma developmentMartin Stork, Sabina Sevcikova, Jiri Minarik, et al.
Haematologica|June 11, 2026
Autologous stem cell transplantation for newly diagnosed multiple myeloma - real-world data from 2,149 Czech patientsTereza Popková, Luděk Pour, Ivan Špička, et al.
BMC Cancer|April 9, 2025
Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma GroupJiri Minarik, Ludek Pour, Vojtech Latal, et al.
Annals of Hematology|April 23, 2023
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysisMartin Stork, Ivan Spicka, Jakub Radocha, et al.
Haematologica|August 30, 2023
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa studyEnrique M Ocio, Yvonne A Efebera, Roman Hájek, et al.
Vnitrni Lekarstvi|May 24, 2018
[Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients]Zdeněk Adam, Eva Ozábalová, Petr Němec, et al.
Cancers|October 27, 2022
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent TherapyJiri Minarik, Jakub Radocha, Alexandra Jungova, et al.
Pageof 4